(Q42507574)

1 November 2017

title

Canine cerebral leishmaniasis: potential role of matrix metalloproteinase-2 in the development of neurological disease (English)

1 reference

1 November 2017

Guilherme D Melo

1

1 reference

1 November 2017

Mary Marcondes

series ordinal

2

1 reference

1 November 2017

Gisele F Machado

series ordinal

3

1 reference

1 November 2017

publication date

11 May 2012

1 reference

Veterinary Immunology and Immunopathology

1 November 2017

published in

1 reference

1 November 2017

volume

148

1 reference

1 November 2017

issue

3-4

1 reference

1 November 2017

page(s)

260-266

1 reference

MMPs in the central nervous system: where the good guys go bad.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Characterization of matrix metalloproteinase-2 and -9 in cerebrospinal fluid of clinically normal dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Tissue inhibitors of metalloproteinases: evolution, structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

The function, composition and analysis of cerebrospinal fluid in companion animals: part II - analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

The paradox of matrix metalloproteinases in infectious disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Presence of antibodies in the aqueous humour and cerebrospinal fluid during Leishmania infections in dogs. Pathological features at the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

A function for a specific zinc metalloprotease of African trypanosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Quantitative zymography: detection of picogram quantities of gelatinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Trypanosoma cruzi GP63 proteins undergo stage-specific differential posttranslational modification and are important for host cell infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Anti-leishmania antibodies in cerebrospinal fluid from dogs with visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Differential alterations in the activity of matrix metalloproteinases within the nervous tissue of dogs in distinct manifestations of visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Levels of matrix metalloproteinase-2 and metalloproteinase-9 in the cerebrospinal fluid of dogs with visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Induction of matrix metalloproteinase-2 in human immunodeficiency virus-1 glycoprotein 120 transgenic mouse brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease gp63.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Leukocyte entry into the CNS of Leishmania chagasi naturally infected dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Glial reactivity in dogs with visceral leishmaniasis: correlation with T lymphocyte infiltration and with cerebrospinal fluid anti-Leishmania antibody titres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

High levels of serum matrix metalloproteinases in dogs with natural visceral leishmaniosis: A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Gelatinase B: a tuner and amplifier of immune functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases and the regulation of tissue remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Polyclonal immunoglobulins (IVIg) induce expression of MMP-9 in microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Comparison of the immunomodulatory effects of L. donovani and L. major excreted–secreted antigens, particulate and soluble extracts and viable parasites on human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases in neuroinflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Immune response regulation by leishmania secreted and nonsecreted antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Pro-inflammatory cytokines modulate matrix metalloproteinase secretion and organic anion transport at the blood-cerebrospinal fluid barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Preanalytical factors affecting the stability of matrix metalloproteinase-2 concentrations in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

Matrix metalloproteinases and diseases of the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2012.05.007

10.1016/J.VETIMM.2012.05.007

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference